Target Druggability from Clarivate Analytics a Bio-IT World Best Practices finalist

PHILADELPHIA, April 24, 2017 – Target Druggability, the latest application from the Clarivate Analytics Drug Research Advisor suite of tools, was selected as a finalists in Bio-IT World’s 2017 Best Practices Awards. The Bio-IT World Best Practices Awards highlight outstanding innovations and developments in the world of life sciences, bringing together a unique group of […]

Clarivate Analytics launches new product suite, reducing risk and saving time for researchers selecting next drug target

Drug Research Advisor enables faster access and more informed decision-making with just one tool, using best in class visualization and analytics. PHILADELPHIA, March 15, 2017  — In the field of drug discovery, selecting a target for preclinical development is difficult, and selecting the right target is arguably the most important step in the entire drug discovery process. Taking […]

Drug Research Advisor from Clarivate Analytics a Finalist in the Fierce Innovation Awards Data Analytics/Business Intelligence Category

PHILADELPHIA, Dec. 22, 2016 — With 65% of drug development failures occurring because the wrong target was selected, researchers need intelligence to support their next choice. Providing this sophisticated business intelligence is why Drug Research Advisor – Target Druggability, a new tool from Clarivate Analytics, was selected as one of five finalists in the Fierce Innovation Awards, Life […]

Clarivate Analytics And Georgetown University Named A Uspto Cancer Moonshot Challenge Winner

Competition aimed at revealing new insights in cancer research and treatments to accelerate progress toward a cure PHILADELPHIA, PA (October 5, 2016) — Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters today announced its third place win with Georgetown University in the USPTO Cancer Moonshot Challenge held by the U.S. Commerce […]